Archive for July 2017
PTO Grants Additional Reviews of Herceptin Patents after Hospira Challenges
The PTO’s Patent Trial and Appeal Board will evaluate the validity of three Genentech patents covering its blockbuster breast cancer treatment Herceptin, following petitions for inter partes review filed by Hospira. Source: Drug Industry Daily
Read MoreIntellipharmaceutics Hit with Lawsuit for Allegedly Hyping Rexista
Intellipharmaceutics artificially inflated its stock prices during the NDA process for its oxycodone product Rexista, a new class-action lawsuit claims. Source: Drug Industry Daily
Read MoreBIO Says BsUFA II Appraisal Must Include Third-Party Evaluator
A third-party evaluator should be used to assess the expanded communications program proposed in the next generation of the FDA’s biosimilar user fees, according to BIO. Source: Drug Industry Daily
Read MoreFDA Withdraws 9 Proposed FDA Regulations and Rules as Part of Trump Deregulation Effort
As part of the Trump administration’s deregulatory push, the FDA has withdrawn nine regulations proposed for the pharmaceutical industry, some in the works for years. Source: Drug Industry Daily
Read MoreWhite House Opioid Commission Recommends National State of Emergency
A White House commission on opioid abuse, established in March by executive order, delivered its initial set of recommendations to President Trump, urging him to declare an immediate, national state of emergency. Source: Drug Industry Daily
Read More4 Hot Biotech Stocks in 2017
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks5.jpg" NAME"4 Hot Biotech Stocks in 2017" ALT"4 Hot Biotech Stocks in 2017"July 31, 2017By Mark Terry, BioSpace.com Breaking News StaffIf 2015 was a super-hot year for mergers and acquisitions in biopharma… Source: BioSpace
Read MoreOnxeo Reports First-Half 2017 Results And Business Update
Life Sciences Jobs … Source: BioSpace
Read MoreBristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×600-deal.jpg" NAME"Bristol-Myers, Clovis Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III" ALT"Bristol-Myers, Clovis Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III"July 31, 2017By Alex Keown, BioSpace… Source: BioSpace
Read More<b>UBM Medica</b>'s <b>Oncology And Society For Integrative Oncology (Sio)</b> Announce Partnership
Life Sciences Jobs … Source: BioSpace
Read MoreFDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-johnson-johnson.jpg" NAME"FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab" ALT"FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab"July 31, 2017(Last Updated: July 31, 2017 at 09:43am PT)By <A HREF"http://www.biospace… Source: BioSpace
Read More